Professional Documents
Culture Documents
Full download at
https://testbankpack.com/p/test-bank-for-advanced-financial-accounting-
canadian-7th-edition-by-beechy-trivedi-macaulay-isbn-0132928930-
9780132928939/
CHAPTER 6
Subsequent-Year Consolidations:
General Approach
This chapter presents the last of the material that is crucial to an understanding of
intercorporate investments, business combinations, and consolidations. The material in
the Appendices to Chapter 6 (parent company investment in non-voting shares and
intercompany bond holdings involving premiums or discounts) are additional aspects that
are interesting and that occasionally arise in Canadian practice, but are not central
concepts of consolidations.
The previous two chapters illustrated intercompany sales of inventory and non-
depreciable capital assets, but avoided the additional complexity of intercompany sales of
depreciable capital assets. Therefore, this chapter begins with a discussion of such asset
transfers.
Appendix 6A addresses those circumstances where the investee company has outstanding
restricted and/or preferred shares in addition to common shares. The treatment of these
Case 6A-1
This case is an adaptation of the comprehensive exam of the 1999 UFE. The students need to
consider the impact of an acquisition on the EPS and accounting policies. There is a potential for
loss of control depending on the method of financing that is selected for the acquisition. Audit
issues also need to be considered.
Case 6A-2
It is not always clear just when a joint venture qualifies for joint venture accounting. In this case, a
joint venture is described in which one partner does have a majority of the board of directors but is
restricted in its control by only 50% voting rights and by a joint venture agreement that requires
consent of both co-ventures for substantive alteration of the terms. The case asks students to
discuss the appropriateness of using four methods of accounting for the investment.
Q6-1: Profits on intercompany sales are unrealized when the merchandise or other assets have not
been resold to outside third parties or been consumed by amortization or depreciation.
Q6-2: The unrealized loss on sale of a capital asset at its fair market value may or may not be
eliminated on consolidation. The key question is whether the reduced fair market value reflects an
impairment in the value of the asset. Under IFRS, an impairment loss exists when the carrying
value of the asset exceeds its recoverable value. The recoverable value of an asset represents the
higher of its (1) fair value less costs to sell, and (2) value in use. If the original carrying value of
the asset still does not exceed the asset’s recoverable value to the consolidated enterprise despite
the low resale value, then the loss would be eliminated. If, on the other hand, the resale value is
low because the recoverable value of the asset has been impaired, the intercompany loss would not
be eliminated.
Q6-3: When assets are sold horizontally between non-wholly owned subsidiaries, the unrealized
profit is in the accounts of the selling company. Further, such sales are treated as upstream sales.
Therefore, 100% of the unrealized gains has to be eliminated in the consolidated financial
statements, allocating 60% to the parent’s owners and the rest, 40%, to the non-controlling interest.
Thus, while the consolidated net income should be adjusted to the full extent of the unrealized gain
of $20,000, 60% or $12,000 should be allocated to the owners of P and 40%, $8,000 should be
allocated to the non-controlling interest.
Q6-4: Equity-basis earnings should be adjusted for the investor company’s share of unrealized
profits from sales between significantly influenced investee corporations. In this example, $20,000
of unrealized profit is in the reported net income of IE1, of which IR has a 30% share. Therefore,
the adjustment to IR’s share of IE1’s earnings will be $6,000.
Q6-5: The profit on an intercompany sale of a depreciable asset is gradually realized over the
productive life of the asset, as the asset is used in the revenue generating activities of the buying
company. In accounting terms, the using up of the asset is reflected by depreciation. Therefore, the
unrealized profit is realized year-by-year as the asset is depreciated.
Q6-6: If a company sells a long-lived asset that is part of its inventory, either upstream or
downstream, it is accounted for as sales revenue with offsetting cost of sales instead of as a gain on
sale. The gross profit on the sale would still be considered unrealized.
Q6-7: IAS 38, Intangible Assets, requires disclosure of the gross carrying amount and any
accumulated amortization at the beginning and end of each period for each class of intangible
assets. Therefore, entities following IFRS will need to keep track of the gross and accumulated
amortization amounts separately in different accounts for various classes of intangible assets. Such
requirements apply to capital assets as well. Hence, under IFRS, adjustments required upon the sale
of an intangible asset with a limited life such as a patent will be the same as the adjustments
required on the sale of a capital asset. However, earlier standards did not impose the same
disclosure requirements as required under IFRS for intangible assets. Therefore, a separate
accumulated amortization amount may not have been maintained in relation to these intangible
assets. In such an event, upon the sale of an intangible asset instead of a capital asset, the two
amounts for the asset account and the accumulated amortization account would have been netted
together.
Q6-8: Consolidated retained earnings is comprised of the parent’s retained earnings, plus the
parent’s share of earnings retained by the subsidiary since the date of acquisition (less any
unrealized profits of the parent, the parent’s share of any unrealized profits of the subsidiary, and
amortization of any fair-value increments, decrements or goodwill).
Q6-9: Ordinarily, any unrealized profit on an upstream intercompany asset sale is deducted from
the recorded carrying value of the asset on the parent’s books and from the consolidated retained
earnings. However, a subsidiary might sell an asset on which an unamortized fair value increment
from the time of the purchase of the subsidiary by the parent exists. In such a case, the unamortized
fair value increment reduces the unrealized profit from the viewpoint of the consolidated entity.
Therefore, the unrealized profit elimination is not for the amount of profit booked by the subsidiary
but is for the difference between the intercompany sales price and the amortized fair value of the
asset (i.e. carrying value of the asset from the consolidated perspective). The remaining gain will
be offset by the unamortized fair value increment adjustment.
Q6-10: In the year of the sale, any unamortized fair value increment on the asset sold is charged to
the gain or loss that has been recorded for the sale. In subsequent years, the charge will be to
consolidated retained earnings.
Q6-11: When the equity method is used for recording, the parent’s share of the subsidiary’s
earnings is included in the parent’s retained earnings. Since the same amounts also appear in the
subsidiary’s retained earnings, the subsidiary’s earnings will be counted twice unless they are
adjusted. Therefore, the process of consolidation under the equity method differs from the process
under the cost method of recording only in that the equity pick-up of earnings made by the parent
must be reversed or eliminated in order to avoid double counting the earnings and the investment
account must be eliminated.
Q6-12: The equity-basis balance represents the parent’s share of the amortized fair values of the
subsidiary’s net assets as originally acquired, plus the parent’s share of the change in the
subsidiary’s net assets since the date of acquisition less/plus any unrealized gains/losses relating to
inter-company transactions at year-end.
Q6-13: Under equity basis reporting, the “equity in earnings” captures all of the effects of the
relationship between the investor and the investee corporations, without disturbing the basic
financial reporting of the activities of the parent or investor corporation. In addition, the “equity in
earnings” reflects the change in the investor’s investment account and all changes in net asset
values that relate to that account.
CASE NOTES
Case 6-1
Role:
First, prepare the separate entity financial statements of ICI and the associated calculations.
Second, compare the financial statements prepared by me with the consolidated statements of ICI
and the separate entity statements of PTI and explain to my friend how the consolidation-related
adjustments may potentially mask the presence of synergy between ICI and PTI. Third, explain to
my friend to what extent the separate entity and consolidated financial statements of ICI
appropriately reflect the true economic operations and situation of ICI.
Constraints:
Since ICI has used IFRS to arrive at its financial statements, all consolidation-related adjustments
required under IFRS need to be undone.
financial statements of ICI and the separate entity financial statements of PTI were prepared and
reported by their respective management and thus may be biased to the extent the respective
management teams have tried to meet their objectives keeping in mind the users of their respective
financial statements and their objectives.
0
Goodwill $475,000
Useful Amort./
FVA Total life year 20X6 20X7 Balance
Inventory $75,000 $75,000 $0
AR 175,000 175,000 0
Buildings 400,000 10 40,000 40,000 40,000 320,000
Plant &
Equipment 300,000 10 30,000 30,000 30,000 240,000
Land 1,000,000 1,000,000
Patents 750,000 10 75,000 75,000 75,000 600,000
Long-term Debt (100,000) 10 (10,000) (10,000) (10,000) (80,000)
Goodwill 475,000 300,000 175,000
Total $3,075,000 $385,000 $435,000 $2,255,000
Eliminate:
Eliminate Intercompany Transactions & Balances
Downstream Sales $1,472,900
Upstream Sales 1,499,680
Inter-company dividends 48,000
Upstream
Beginning inventory $100,000
Realized gain 37,000
Downstream
Beg. RE PTI
Ending RE $909,674
Less income for the year (249,834)
Add dividends declared for the year 60,000
Beg. RE 719,840
RE at acquisition 450,000
Change in RE 269,840
Less FVA amortization 20X6 (385,000)
Less gain on sale of P&E (100,000)
Add realization of gain 10,000
Unrealized gain beginning upstream (37,000)
Adj. change RE of PTI (242,160)
ICI's share (193,728)
Unrealized gain beginning downstream (18,000)
Consolidated Beg. RE ICI $1,386,732
RE Ending 909,674
RE acquisition (450,000)
Change in RE 459,674
Less FVA amortization 20X6 (385,000)
Less FVA amortization 20X7 (435,000)
Less Unrealized gain ending (55,500)
Less unrealized gain P&E (80,000)
Adj. change in RE (495,826)
Parent's share (396,661)
Consolidated End RE ICI $1,613,857
PTI, it is important to understand that such comparison may not necessarily shed light on the
presence or absence of synergy between ICI and PTI.
The provided returns on equity of PTI and ICI at the time of acquisition are 20.42% and 10.69%
respectively. In comparison, the returns on equity of PTI and ICI for 20X7, as calculated above, are
17.72% and 10.15%. Thus, both returns on equity in 20X7 are lower than their comparatives at the
time of acquisition. However, notice that both these returns of equity are far above the alternate
returns on equity calculated based on the consolidated numbers, 5.94% and 7.32%. In short, the
returns on equity based on the separate entity financial statements of PTI and ICI are not as bad as
those based on the consolidated financial statements. The reasons for this disparity are:
The loss of $300,000 recognized in the consolidated SCI relating to the impairment of the
goodwill arising from the acquisition of PTI,
The fair value adjustment amortization of $135,000 relating to the identifiable net assets of PTI
on the consolidated SCI in 20X7,
The unrealized gains present in the ending inventories of PTI and ICI relating to the inter-
company sales of inventory between them being higher by $23,000 compared to the unrealized
gains in the beginning inventories of the two companies.
Note that these additional expenses/adjustments do not show up on the separate entity financial
statements of PTI. Thus, comparing the consolidated results with the results of PTI at the time of
its acquisition, based on its separate entity statements at that time, is incorrect. Nevertheless, note
that the consolidated adjustments highlighted above are done for genuine reasons. When one
company controls another, the consolidated statements should represent only the results of those
REFERENCES.
[1] Zinn: Berl. Klin. Woch., No. 50, 1899.
[2] Collis, E. L.: Special Report on Dangerous or Injurious Processes in
the Smelting of Materials containing Lead, p. 6. 1910.
[3] Grissolle: Thèse, Paris, 1835.
[4] Meillère, G.: Le Saturnisme, p. 122. Paris, 1903.
[5] Amino: Archiv. Ital. di Clin. Med., 1893.
[6] Chatin: Province Méd., Lyon, No. 4, 1892.
[7] Harnack: Deutsch. Med. Woch., 1897.
[8] Mayer: Virchow’s Archiv, 1881.
[9] Hunter, John: Observations of the Diseases of the Army in Jamaica.
London, 1788.
[10] Mott, F.: Archives of Neurology and Psychiatry, vol. iv., p. 117.
CHAPTER VIII
EXCRETION OF LEAD
A = Polymorphonuclears.
B = Lymphocytes.
C = Large hyaline.
D = Eosinophile.
E = Transitional.
F = Basophile.
G = Microcytes.
H = Megalocytes.
I = Poikilocytes.
J = Nucleated red.
K = Plehn’s bodies.
Corpuscles, Thoma-Zeiss.
Hæmaglobin, Haldane’s instrument.
Films, stained Leishman.
[A]
A = Polymorphonuclears.
B = Lymphocytes.
C = Mononuclears.
D = Eosinophiles.
E = Myelocytes.
F = Basophiles.
G = Microcytes.
H = Megalocytes.
= Poikilocytes.
J = Vacuolated red cells.
K = Normoblasts.
REFERENCES.
[1] Meillère, G.: Le Saturnisme. Paris, 1903.
[2] Blyth, Wynter: Proc. Chem. Soc, 1887-88.
[3] Peyrusson and Pillault: Meillère’s Le Saturnisme, chap. iv.
[4] Newton Pitt: Trans. Path. Soc, No. 42, 1891.
[5] Glibert: Le Saturnisme Expérimental: Extrait des Rapports Ann. de
l’Inspect. du Travail, Brussels, 1906.
[6] Moritz: Mediz. Woch., St. Petersburg, 1901.
[7] Schmidt: Arch. für Hygiene, vol. lxiii., p. 1, 1907.
[8] Glibert: Ibid.
[9] Boycott: Journal of Hygiene, 1910.
CHAPTER IX
THE NERVOUS SYSTEM